Developing targeted therapies to combine with venetoclax in acute myeloid leukemia (AML)
What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
Current thought on treating chronic lymphocytic leukemia
An update on kinase inhibitors from EHA 2017
Panel discussion on mantle cell lymphoma
Constantine Tam et al.